Obalon Therptcs Stock Price, News & Analysis (NASDAQ:OBLN)

$7.50 0.04 (0.54 %)
(As of 12/13/2017 09:43 AM ET)
Previous Close$7.46
Today's Range$7.37 - $7.68
52-Week Range$6.91 - $13.18
Volume28,600 shs
Average Volume50,013 shs
Market Capitalization$130.81 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Obalon Therptcs (NASDAQ:OBLN)

Obalon Therptcs logoObalon Therapeutics, Inc. is a United States-based commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in obese patients. The Obalon balloon system is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. All balloons must be removed six months after the first balloon is placed. The Obalon balloon system intends to provide patients and physicians with a reversible and repeatable weight loss solution in an outpatient setting, without altering patient anatomy or requiring surgery. The Company has received Premarket approval (PMA) for its Obalon balloon system based on the results of its United States pivotal clinical trial, referred to as the SMART trial.

Receive OBLN News and Ratings via Email

Sign-up to receive the latest news and ratings for OBLN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices & Implants
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:OBLN
CUSIPN/A
Phone+1-858-4802400

Debt

Debt-to-Equity Ratio0.21%
Current Ratio8.78%
Quick Ratio8.65%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$3.39 million
Price / Sales38.58
Cash FlowN/A
Price / CashN/A
Book Value$3.83 per share
Price / Book1.96

Profitability

Trailing EPS($1.93)
Net Income$-20,460,000.00
Net Margins-459.54%
Return on Equity-59.77%
Return on Assets-47.02%

Miscellaneous

Employees11
Outstanding Shares17,440,000

Obalon Therptcs (NASDAQ:OBLN) Frequently Asked Questions

What is Obalon Therptcs' stock symbol?

Obalon Therptcs trades on the NASDAQ under the ticker symbol "OBLN."

How were Obalon Therptcs' earnings last quarter?

Obalon Therptcs (NASDAQ:OBLN) released its earnings results on Friday, November, 3rd. The company reported ($0.55) EPS for the quarter, missing the Zacks' consensus estimate of ($0.43) by $0.12. The firm had revenue of $2.79 million for the quarter, compared to analyst estimates of $2.95 million. Obalon Therptcs had a negative return on equity of 59.77% and a negative net margin of 459.54%. View Obalon Therptcs' Earnings History.

When will Obalon Therptcs make its next earnings announcement?

Obalon Therptcs is scheduled to release their next quarterly earnings announcement on Thursday, February, 22nd 2018. View Earnings Estimates for Obalon Therptcs.

Where is Obalon Therptcs' stock going? Where will Obalon Therptcs' stock price be in 2017?

3 Wall Street analysts have issued 1 year price objectives for Obalon Therptcs' shares. Their forecasts range from $4.00 to $17.00. On average, they expect Obalon Therptcs' share price to reach $12.00 in the next twelve months. View Analyst Ratings for Obalon Therptcs.

What are Wall Street analysts saying about Obalon Therptcs stock?

Here are some recent quotes from research analysts about Obalon Therptcs stock:

  • 1. BTIG Research analysts commented, "Agreements, Navigation, and Market Growth We hosted CEO Andy Rasdal and CFO Bill Plovanic for a series of investor meetings. Overall, management remained upbeat about the long-term opportunity, underpinned by the recently announced agreement with Sono Bello (Private) and potential incremental revenue stream afforded by the yet-to-be approved navigation system.   Sono Bello adds a sizable aesthetic practice to existing customer base. OBLN’s agreement with Sono Bello is important for a variety of reasons. First, the agreement provides a significant boost to the account base (40+ locations, 100+ physicians) and adds a focus from Sono Bello to offer a novel weight loss solution. Second, the agreement will help with other potential plastic surgeon customers who may look to Sono Bello for indications of patient interest. We expect Sono Bello to roll OBLN out in stages as it figures out how best to offer balloons and also benefit its own liposuction practice.   Navigation, while still not FDA cleared, removes a barrier to entry. Mgmt. provided incremental details on the navigation system including expectations to be substantially less expensive than X-Ray. We believe the Navigation system may be approved in 1H18 as PMA supplements usually take approximately 6 months and it has been submitted." (11/16/2017)
  • 2. According to Zacks Investment Research, "Obalon Therapeutics, Inc. is a medical device company. It focused on developing and commercializing medical devices to treat obese and overweight. The company's product consists of Obalon balloon system, the first swallowable, gas-filled intragastric balloon designed to provide progressive and sustained weight loss in obese patients. Obalon Therapeutics, Inc. is based in San Diego, California. " (11/16/2017)
  • 3. Northland Securities analysts commented, "We are initiating coverage of Obalon Therapeutics with an Underperform rating / $6 PT. We are concerned that forward estimates are too high, the science is unclear, the logistical issues of 3- intragastric balloon (IGB) procedures remain, and finally, ponying up $8,000 or so in a cash-pay procedure for a 15 lb. weight loss makes this product more suitable for a wealthy, event-driven" motivated patient, therefore making the realistic TAM quite small." (6/21/2017)
  • 4. Canaccord Genuity analysts commented, "We reiterate our BUY rating following marketing meetings with management. We recently hosted two days of upbeat investor meetings with Obalon CEO Andy Rasdal as well as CFO Bill Plovanic. We came away from those meetings with a clearer understanding of investor sentiment as well as early commercial traction in the US launch." (5/18/2017)

Who are some of Obalon Therptcs' key competitors?

Who are Obalon Therptcs' key executives?

Obalon Therptcs' management team includes the folowing people:

  • Kim P Kamdar, Chairman of the Board (Age 49)
  • Andrew Rasdal, President, Chief Executive Officer, Director (Age 58)
  • William J. Plovanic, Chief Financial Officer (Age 47)
  • Kelly Huang Ph.D., Chief Operating Officer (Age 48)
  • Nooshin Hussainy, Vice President - Finance (Age 58)
  • Steve Johnson, Vice President - Operations (Age 58)
  • Matthew Norwood, Vice President of Sales (Age 41)
  • Lisa Metzner, Vice President of Marketing (Age 47)
  • Amy VandenBerg, Vice President - Regulatory and Clinical Affairs (Age 41)
  • Donald Young, Vice President of Quality Assurance (Age 58)

When did Obalon Therptcs IPO?

(OBLN) raised $75 million in an IPO on Thursday, October 6th 2016. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. UBS Investment Bank, Canaccord Genuity and Stifel served as the underwriters for the IPO and BTIG was co-manager.

Who owns Obalon Therptcs stock?

Obalon Therptcs' stock is owned by many different of retail and institutional investors. Top institutional investors include C WorldWide Group Holding A S (1.58%), Granite Investment Partners LLC (0.62%), Wasatch Advisors Inc. (0.52%) and Emerald Mutual Fund Advisers Trust (0.38%). Company insiders that own Obalon Therptcs stock include Kim P Kamdar and Matthew Norwood. View Institutional Ownership Trends for Obalon Therptcs.

Who sold Obalon Therptcs stock? Who is selling Obalon Therptcs stock?

Obalon Therptcs' stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc.. View Insider Buying and Selling for Obalon Therptcs.

Who bought Obalon Therptcs stock? Who is buying Obalon Therptcs stock?

Obalon Therptcs' stock was bought by a variety of institutional investors in the last quarter, including Granite Investment Partners LLC, C WorldWide Group Holding A S and Emerald Mutual Fund Advisers Trust. Company insiders that have bought Obalon Therptcs stock in the last two years include Kim P Kamdar and Matthew Norwood. View Insider Buying and Selling for Obalon Therptcs.

How do I buy Obalon Therptcs stock?

Shares of Obalon Therptcs can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Obalon Therptcs' stock price today?

One share of Obalon Therptcs stock can currently be purchased for approximately $7.50.

How big of a company is Obalon Therptcs?

Obalon Therptcs has a market capitalization of $130.81 million and generates $3.39 million in revenue each year. The company earns $-20,460,000.00 in net income (profit) each year or ($1.93) on an earnings per share basis. Obalon Therptcs employs 11 workers across the globe.

How can I contact Obalon Therptcs?

Obalon Therptcs' mailing address is 5421 Avenida Encinas Ste F, CARLSBAD, CA 92008-4410, United States. The company can be reached via phone at +1-858-4802400 or via email at [email protected]


MarketBeat Community Rating for Obalon Therptcs (OBLN)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  77 (Vote Outperform)
Underperform Votes:  58 (Vote Underperform)
Total Votes:  135
MarketBeat's community ratings are surveys of what our community members think about Obalon Therptcs and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Obalon Therptcs (NASDAQ:OBLN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.502.502.503.00
Ratings Breakdown: 1 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $13.50$13.50$15.25$18.33
Price Target Upside: 73.52% upside50.67% upside84.18% upside80.62% upside

Obalon Therptcs (NASDAQ:OBLN) Consensus Price Target History

Price Target History for Obalon Therptcs (NASDAQ:OBLN)

Obalon Therptcs (NASDAQ:OBLN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/16/2017BTIG ResearchReiterated RatingBuy$15.00N/AView Rating Details
11/3/2017Northland SecuritiesReiterated RatingSell$4.00N/AView Rating Details
5/18/2017Canaccord GenuityReiterated RatingBuyLowView Rating Details
10/31/2016Stifel NicolausInitiated CoverageBuy$18.00N/AView Rating Details
(Data available from 12/13/2015 forward)

Earnings

Obalon Therptcs (NASDAQ:OBLN) Earnings History and Estimates Chart

Earnings by Quarter for Obalon Therptcs (NASDAQ:OBLN)

Obalon Therptcs (NASDAQ OBLN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/21/2018($0.47)N/AView Earnings Details
11/3/2017Q3 2017($0.43)($0.55)$2.95 million$2.79 millionViewN/AView Earnings Details
8/2/2017Q2 2017($0.43)($0.46)$1.77 million$1.96 millionViewListenView Earnings Details
5/10/2017Q1 2017($0.33)($0.47)$1.60 million$1.47 millionViewN/AView Earnings Details
11/11/2016Q3 2016($0.32)($5.46)$0.70 million$0.77 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Obalon Therptcs (NASDAQ:OBLN) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.96 EPS
Next Year EPS Consensus Estimate: $-1.68 EPS

Dividends

Dividend History for Obalon Therptcs (NASDAQ:OBLN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Obalon Therptcs (NASDAQ OBLN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 16.40%
Institutional Ownership Percentage: 44.05%
Insider Trades by Quarter for Obalon Therptcs (NASDAQ:OBLN)
Insider Trades by Quarter for Obalon Therptcs (NASDAQ:OBLN)

Obalon Therptcs (NASDAQ OBLN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/12/2016Kim P KamdarDirectorBuy13,400$15.00$201,000.00View SEC Filing  
10/12/2016Matthew NorwoodVPBuy1,000$15.00$15,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Obalon Therptcs (NASDAQ OBLN) News Headlines

Source:
DateHeadline
Zacks: Analysts Anticipate Obalon Therptcs (OBLN) Will Announce Quarterly Sales of $3.52 MillionZacks: Analysts Anticipate Obalon Therptcs (OBLN) Will Announce Quarterly Sales of $3.52 Million
www.americanbankingnews.com - December 11 at 8:14 AM
Analyzing Obalon Therptcs (OBLN) & OrthoPediatrics (KIDS)Analyzing Obalon Therptcs (OBLN) & OrthoPediatrics (KIDS)
www.americanbankingnews.com - December 11 at 1:26 AM
Zacks: Analysts Expect Obalon Therptcs (OBLN) to Announce -$0.48 EPSZacks: Analysts Expect Obalon Therptcs (OBLN) to Announce -$0.48 EPS
www.americanbankingnews.com - December 9 at 7:16 PM
Obalon Therptcs (OBLN) versus Its Rivals Critical ContrastObalon Therptcs (OBLN) versus Its Rivals Critical Contrast
www.americanbankingnews.com - December 6 at 1:28 AM
Comparing Obalon Therptcs (OBLN) & Its CompetitorsComparing Obalon Therptcs (OBLN) & Its Competitors
www.americanbankingnews.com - December 4 at 8:00 AM
Contrasting Obalon Therptcs (OBLN) & Its RivalsContrasting Obalon Therptcs (OBLN) & Its Rivals
www.americanbankingnews.com - December 1 at 2:24 PM
Head-To-Head Review: Obalon Therptcs (OBLN) versus Its CompetitorsHead-To-Head Review: Obalon Therptcs (OBLN) versus Its Competitors
www.americanbankingnews.com - November 28 at 7:56 AM
Critical Survey: Endologix (ELGX) & Obalon Therptcs (OBLN)Critical Survey: Endologix (ELGX) & Obalon Therptcs (OBLN)
www.americanbankingnews.com - November 27 at 12:15 PM
Obalon Therptcs (OBLN) Given Consensus Rating of "Hold" by AnalystsObalon Therptcs (OBLN) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - November 27 at 4:10 AM
$3.52 Million in Sales Expected for Obalon Therptcs (OBLN) This Quarter$3.52 Million in Sales Expected for Obalon Therptcs (OBLN) This Quarter
www.americanbankingnews.com - November 23 at 2:46 AM
ETFs with exposure to Obalon Therapeutics, Inc. : November 21, 2017ETFs with exposure to Obalon Therapeutics, Inc. : November 21, 2017
finance.yahoo.com - November 22 at 6:21 AM
Obalon Therptcs (OBLN) versus The Competition Financial ReviewObalon Therptcs (OBLN) versus The Competition Financial Review
www.americanbankingnews.com - November 22 at 5:26 AM
Zacks: Analysts Anticipate Obalon Therptcs (OBLN) to Post -$0.48 EPSZacks: Analysts Anticipate Obalon Therptcs (OBLN) to Post -$0.48 EPS
www.americanbankingnews.com - November 21 at 9:26 PM
Are You Backing The Right Horse With Obalon Therapeutics Inc (OBLN)?Are You Backing The Right Horse With Obalon Therapeutics Inc (OBLN)?
finance.yahoo.com - November 21 at 8:55 AM
Obalon Therptcs (OBLN) versus The Competition Critical AnalysisObalon Therptcs (OBLN) versus The Competition Critical Analysis
www.americanbankingnews.com - November 20 at 5:24 PM
Obalon Therptcs (OBLN) and The Competition Head-To-Head ComparisonObalon Therptcs (OBLN) and The Competition Head-To-Head Comparison
www.americanbankingnews.com - November 18 at 1:32 PM
Contrasting Obalon Therptcs (OBLN) and Its PeersContrasting Obalon Therptcs (OBLN) and Its Peers
www.americanbankingnews.com - November 17 at 5:22 AM
Obalon Therptcs (OBLN) Receives Buy Rating from BTIG ResearchObalon Therptcs (OBLN) Receives Buy Rating from BTIG Research
www.americanbankingnews.com - November 16 at 9:42 AM
Obalon Therptcs (OBLN) Upgraded by Zacks Investment Research to HoldObalon Therptcs (OBLN) Upgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - November 16 at 6:32 AM
Obalon Therptcs (OBLN) & Its Peers Head to Head AnalysisObalon Therptcs (OBLN) & Its Peers Head to Head Analysis
www.americanbankingnews.com - November 13 at 5:14 AM
UBS AG Cuts OBALON THERPTCS (OBLN) Price Target to $16.00UBS AG Cuts OBALON THERPTCS (OBLN) Price Target to $16.00
www.americanbankingnews.com - November 12 at 8:39 AM
ETFs with exposure to Obalon Therapeutics, Inc. : November 8, 2017ETFs with exposure to Obalon Therapeutics, Inc. : November 8, 2017
finance.yahoo.com - November 9 at 7:59 AM
Contrasting Obalon Therptcs (OBLN) and Its CompetitorsContrasting Obalon Therptcs (OBLN) and Its Competitors
www.americanbankingnews.com - November 7 at 5:17 PM
Obalon Therapeutics, Inc. :OBLN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017Obalon Therapeutics, Inc. :OBLN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017
finance.yahoo.com - November 7 at 4:38 PM
Obalon Announces Upcoming Conference PresentationsObalon Announces Upcoming Conference Presentations
finance.yahoo.com - November 7 at 8:05 AM
Obalon Therptcs (OBLN) PT Lowered to $15.00 at BTIG ResearchObalon Therptcs (OBLN) PT Lowered to $15.00 at BTIG Research
www.americanbankingnews.com - November 6 at 8:08 AM
China Kanghui Holdings (KH) and Obalon Therptcs (OBLN) Head-To-Head AnalysisChina Kanghui Holdings (KH) and Obalon Therptcs (OBLN) Head-To-Head Analysis
www.americanbankingnews.com - November 6 at 7:24 AM
Northland Securities Reaffirms Sell Rating for Obalon Therptcs (OBLN)Northland Securities Reaffirms Sell Rating for Obalon Therptcs (OBLN)
www.americanbankingnews.com - November 5 at 1:34 PM
Obalon Therapeutics, Inc. to Host Earnings CallObalon Therapeutics, Inc. to Host Earnings Call
finance.yahoo.com - November 4 at 8:19 AM
Obalon Therptcs (OBLN) Issues Quarterly  Earnings ResultsObalon Therptcs (OBLN) Issues Quarterly Earnings Results
www.americanbankingnews.com - November 3 at 9:30 PM
Obalon Therptcs (OBLN) Given Average Rating of "Hold" by AnalystsObalon Therptcs (OBLN) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - November 2 at 3:50 AM
Obalon Therptcs (OBLN) Set to Announce Quarterly Earnings on FridayObalon Therptcs (OBLN) Set to Announce Quarterly Earnings on Friday
www.americanbankingnews.com - October 28 at 10:38 AM
Obalon Schedules Third Quarter 2017 Financial Results Conference Call for November 3, 2017 at 8:30 a.m. Eastern TimeObalon Schedules Third Quarter 2017 Financial Results Conference Call for November 3, 2017 at 8:30 a.m. Eastern Time
finance.yahoo.com - October 27 at 8:56 AM
OBALON THERPTCS (OBLN) Expected to Announce Quarterly Sales of $2.95 MillionOBALON THERPTCS (OBLN) Expected to Announce Quarterly Sales of $2.95 Million
www.americanbankingnews.com - October 15 at 5:32 AM
Zacks: Analysts Anticipate Obalon Therptcs (OBLN) to Announce -$0.43 Earnings Per ShareZacks: Analysts Anticipate Obalon Therptcs (OBLN) to Announce -$0.43 Earnings Per Share
www.americanbankingnews.com - October 13 at 2:18 PM
Obalon Therptcs (OBLN) Receives Average Rating of "Hold" from AnalystsObalon Therptcs (OBLN) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - October 8 at 2:56 AM
Financial Analysis: Second Sight Medical Products (EYES) vs. Obalon Therptcs (OBLN)Financial Analysis: Second Sight Medical Products (EYES) vs. Obalon Therptcs (OBLN)
www.americanbankingnews.com - October 1 at 12:18 PM
Head to Head Analysis: Obalon Therptcs (OBLN) & Second Sight Medical Products (EYES)Head to Head Analysis: Obalon Therptcs (OBLN) & Second Sight Medical Products (EYES)
www.americanbankingnews.com - September 23 at 12:26 AM
Obalon Therptcs (OBLN) Receives Average Recommendation of "Hold" from AnalystsObalon Therptcs (OBLN) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - September 13 at 2:50 AM
Kelly Huang, Ph.D., Joins Obalon Therapeutics, Inc. Executive TeamKelly Huang, Ph.D., Joins Obalon Therapeutics, Inc. Executive Team
finance.yahoo.com - September 8 at 6:39 AM
OBALON THERPTCS (OBLN) and HeartWare International (HTWR) Critical ComparisonOBALON THERPTCS (OBLN) and HeartWare International (HTWR) Critical Comparison
www.americanbankingnews.com - September 4 at 4:08 PM
Head to Head Survey: OBALON THERPTCS (OBLN) & Glaukos Corporation (GKOS)Head to Head Survey: OBALON THERPTCS (OBLN) & Glaukos Corporation (GKOS)
www.americanbankingnews.com - September 2 at 4:22 AM
Critical Review: OBALON THERPTCS (OBLN) versus HeartWare International (HTWR)Critical Review: OBALON THERPTCS (OBLN) versus HeartWare International (HTWR)
www.americanbankingnews.com - August 31 at 8:08 AM
Obalon Therptcs (OBLN) and Trivascular Technologies (TRIV) Head to Head ComparisonObalon Therptcs (OBLN) and Trivascular Technologies (TRIV) Head to Head Comparison
www.americanbankingnews.com - August 27 at 12:28 PM
Analyzing Obalon Therptcs (OBLN) and St Jude Medical (STJ)Analyzing Obalon Therptcs (OBLN) and St Jude Medical (STJ)
www.americanbankingnews.com - August 24 at 12:20 AM
Obalon Therptcs (OBLN) Expected to Post Quarterly Sales of $2.95 MillionObalon Therptcs (OBLN) Expected to Post Quarterly Sales of $2.95 Million
www.americanbankingnews.com - August 20 at 3:16 AM
Analyzing HeartWare International (HTWR) & OBALON THERPTCS (OBLN)Analyzing HeartWare International (HTWR) & OBALON THERPTCS (OBLN)
www.americanbankingnews.com - August 19 at 12:30 PM
Obalon Therptcs (OBLN) Receives Consensus Rating of "Hold" from AnalystsObalon Therptcs (OBLN) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - August 19 at 2:42 AM
Obalon Therptcs (NASDAQ:OBLN) Issues  Earnings ResultsObalon Therptcs (NASDAQ:OBLN) Issues Earnings Results
www.americanbankingnews.com - August 3 at 4:34 PM
Investor Network: Obalon Therapeutics, Inc. to Host Earnings CallInvestor Network: Obalon Therapeutics, Inc. to Host Earnings Call
finance.yahoo.com - August 3 at 6:32 AM

SEC Filings

Obalon Therptcs (NASDAQ:OBLN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Obalon Therptcs (NASDAQ:OBLN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Obalon Therptcs (NASDAQ OBLN) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.